Progesterone Market Potential is Huge
Progesterone, a steroid hormone synthesized by the placenta, ovaries and adrenal glands, is essential for reproductive function and regulation of the menstrual cycle, such as the initiation and maintenance of ovulation and pregnancy, and has a significant protective effect on the endometrium in women. Under the background of my country's liberalization of the three-child policy and the rising demand for assisted reproductive drugs, it is expected that the downstream market demand for progesterone in China will also have a large room for growth in the future.
In the public hospital market, the sales of progesterone preparations in my country increased from 1.141 billion yuan to 1.279 billion yuan from 2017 to 2021, with a compound growth rate of 2.89% during the period. The decline in the market size of progesterone preparations in public hospitals in 2020 is mainly due to the impact of the epidemic and the decline in the birth rate of newborns.
In the retail market, the sales of progesterone preparations showed a stable trend. From 2017 to 2021, the sales of progesterone preparations in my country increased from 170 million yuan to 176 million yuan in retail channels.
In recent years, the export volume of progesterone has increased substantially, and the export price has remained basically stable.
2026-07-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
Beyond Compliance: Building Quality Maturity
-
Is the class solidified? From Biotech to Pharma
-
The IPO of the Largest Domestic Metronidazole API Manufacturer has Passed the Meeting
-
PharmaReg AfriSummit
-
Two Types Of Progesterone Only Pill That Commonly Used
-
2022 PHARMA X FOOD X FINE CHEMICAL RAW MATERIALS MATCH MEETING Successfully Held!
-
KOREA PHARM & BIO 2021
Recommend Reading
-
Aldi Expands Its Ingredient Ban
-
FDA Dye Phase-Out Push Opens a Bigger Window for Natural Color Solutions
-
IPEC Updates Excipient Qualification Guidance
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
-
Pharmaceutical Tariffs Put Ingredients Back in Focus
-
Fundamentals Weakened, Polyester Staple Fiber Price Center of Gravity Shifts Lower
-
FDA Tracks Industry Dye Removal
-
Syngenta Bee Pesticide Protest Shows the Pressure Building Around Crop Protection Giants
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
-
This Week's PVC Market Continues to Rise (3.2-3.5) in China